$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Following this training protocol, it has been documented that only the QT animals demonstrate superior locomotor function when compared to the other groups18. However, due to the nature of our lab, our primary focus is to investigate non-locomotor benefits of activity-based task-specific training (ABT), including bladder, bowel, and sexual function. For instance, we have previously published data that shows LT results in an exercise-induced reduction of polyuria in both QT and FT groups of SCI rats (Figure 4)17. Also, an injury-induced decrease in transforming growth factor-β (TGF-β) expression in the kidney's, indicative of an altered immune response, was not seen in QT and FT groups, which had TGF-β levels similar to sham (no injury) animals. In the same study17, awake cystometry was performed before euthanasia and tissue collection. The maximum amplitude of bladder contractions during void cycles was not significantly different across sham, QT, and FT groups, while NT groups remained significantly altered. Together, these data indicate a positive exercise outcome on kidney health and bladder function, thus improving urinary function after SCI.
The mechanisms underlying polyuria within the SCI population is currently not clear but is likely multi-factorial32. Some have hypothesized, for example, that pooling of fluid in the lower limbs while SCI individuals are in a wheelchair can lead to fluid overload and increased fluid elimination during postural shifts (such as moving from sitting to lying)33. Such an explanation does not hold for the pre-clinical model, which has led us to focus initially on arginine vasopressin (AVP), the hormone which controls fluid homeostasis in the body and can be modulated with exercise. AVP controls fluid homeostasis through activation of the V2 receptor in the kidneys which facilitates water resorption from the renal collecting ducts34. Preliminary evidence from a pilot experiment (chronic time-point with one lesion severity - 210 kdyn impact force) indicate a beneficial effect of exercise (LT and FT) on V2 receptor levels in the rat kidney (Figure 5).

Figure 1: Custom-made harnesses sized for male Wistar rats. Both QT and NT animals are placed in the same type of jacket (A) allowing for the use of hind limbs in the case of QT animals. There are additional straps sewed onto the harness used for FT animals (B) to raise up the hind limbs, assuring no body weight support. The large hook-and-loop material portions of the harness allow for easy adjustments to different sized animals and to any changes in the size of an individual animal over time. Please click here to view a larger version of this figure.

Figure 2: Training station setup. Body weight support mechanism surrounding the treadmill for either NT (far left), QT (middle), or FT (right) groups. Please click here to view a larger version of this figure.

Figure 3: Training station with animals. Top (A) and (B) side views showing body weight support mechanism and location of attachment support clips to the harnesses. Note that the hind limbs of the FT animal (B) is raised and off the treadmill belt. Inset (C) portrays a closer view of the clip fastened to the harness. Please click here to view a larger version of this figure.

Figure 4: ABT effects on rat polyuria after SCI. The total volume of urine output (A) increased after SCI (*; p < 0.05) and returned closer to baseline after 9 weeks of LT training in both QT and FT groups but remained increased in the NT group relative to the trained groups (#; p < 0.05). All groups demonstrated increased urine output compared to baseline at 9 weeks and increased void volume (B). It is important to note that the number of voids (C) and the amount of water intake (D) remained the same across all groups. Values are means ± standard error. This figure is republished with author permission17. Please click here to view a larger version of this figure.

Figure 5: ABT effects on rat kidney. Western blot results for rat kidney levels of V2 receptors in 5 groups of 4 rats each (20 total), showing expression levels for the protein bands provided in panel A and group mean densitometry analysis results of the bands (using ImageJ; OD = optical density) in panel B, indicating a significant (*; p < 0.05) decrease in receptors at a chronic time-point (12 weeks) post-SCI and no decrease relative to baseline (sham surgical controls) for groups receiving 10 weeks of one-hour daily ABT. Error bars represent standard error. Please click here to view a larger version of this figure.
| Ketamine/Xylazine Dose Chart | | |
| Effective dose: | ***Using 100 mg/mL ketamine stock and 20 mg/mL xylazine stock*** |
| 80 mg/kg ketamine | | | | |
| 10 mg/kg xylazine | | | | |
| 1.0 mL mixture Injection = 0.62 mL ketamine stock (100 mg/mL) + 0.38 mL xylazine stock (20 mg/mL) |
| Animal Weight | Mixture Injection | Animal Weight | Mixture Injection |
| (g) | (mL) | | (g) | (mL) |
| 100 | 0.13 | | 275 | 0.36 |
| 105 | 0.14 | | 285 | 0.37 |
| 110 | 0.14 | | 290 | 0.38 |
| 115 | 0.15 | | 300 | 0.39 |
| 120 | 0.16 | | 305 | 0.4 |
| 125 | 0.16 | | 310 | 0.4 |
| 130 | 0.17 | | 315 | 0.41 |
| 135 | 0.18 | | 320 | 0.42 |
| 140 | 0.18 | | 325 | 0.42 |
| 145 | 0.19 | | 330 | 0.43 |
| 150 | 0.2 | | 335 | 0.44 |
| 155 | 0.2 | | 340 | 0.44 |
| 160 | 0.21 | | 345 | 0.45 |
| 165 | 0.21 | | 350 | 0.46 |
| 170 | 0.22 | | 355 | 0.46 |
| 175 | 0.23 | | 360 | 0.47 |
| 180 | 0.23 | | 365 | 0.47 |
| 185 | 0.24 | | 370 | 0.48 |
| 190 | 0.25 | | 375 | 0.49 |
| 195 | 0.25 | | 380 | 0.49 |
| 200 | 0.26 | | 385 | 0.5 |
| 205 | 0.27 | | 390 | 0.51 |
| 210 | 0.27 | | 395 | 0.51 |
| 215 | 0.28 | | 400 | 0.52 |
| 220 | 0.29 | | 410 | 0.53 |
| 225 | 0.29 | | 420 | 0.55 |
| 230 | 0.3 | | 430 | 0.56 |
| 235 | 0.31 | | 440 | 0.57 |
| 240 | 0.31 | | 450 | 0.59 |
| 245 | 0.32 | | 460 | 0.6 |
| 250 | 0.33 | | 470 | 0.61 |
| 255 | 0.33 | | 480 | 0.62 |
| 260 | 0.34 | | 490 | 0.64 |
| 265 | 0.34 | | 500 | 0.65 |
| 270 | 0.35 | | 510 | 0.66 |
Table 1: Anesthesia dosage chart based upon individual animal's weight.
Training Time
(min) | Speed (cm/s) | Duration (min) |
| 0-1 | 6 | 1 |
| 1-2 | 8.4 | 1 |
| 2-3 | 10.8 | 1 |
| 3-8 | 13.2 | 5 |
| 8-13 | 10.8 | 5 |
| 13-28 | 13.2 | 15 |
| 28-33 | 10.8 | 5 |
| 33-38 | 6 | 5 |
| 38-43 | 8.4 | 5 |
| 43-58 | 13.2 | 15 |
Table 2: Training regimen of speed settings the treadmill should be on corresponding to the time spent at each speed.